DIATOMIC Launches its Final Call to Distribute up to €200K Equity-Free Funding

In its second and final open call for application experiments, DIATOMIC is offering a total of €1.610.000 equity-free funding plus acceleration services to the best startups/ SMEs and Competence Centers across the European microelectronics industry.

DIATOMIC, an exclusive network of Digital Innovation Hubs - set under the EC's Smart Anything Everywhere Initiative, aims to accelerate solutions that apply electronic components, sensors, smart objects and systems across health, agrifood and manufacturing sectors. With this in mind, DIATOMIC offers a 9 - 15 months acceleration programme, and will distribute up to €1.610.000 equity-free funding, with selected consortia receiving up to €200,000 per application experiment.

Eligibility

  • We are only looking for small consortia of a maximum of 3 partners from the EU and H2020 associated countries;
  • Your consortium must include technology providers in the areas of advanced microelectronics & smart systems integration (i.e. Centers of Competence), as well as tech adopters/ users, namely: startups/ SMEs active in health, agrifood, manufacturing;
  • The consortia is to be led by industrial partners - SMEs & midcaps. DIATOMIC also provides assistance in partner search/ matchmaking;
  • Your solution needs to demonstrate clear value to the European economy and society. The minimum TRL required at time of proposal submission should be at the level 3, aiming towards the digitization of products/processes.

The Offer

Top consortiaselected after the closing date on 31stJanuary, 2019, will take part in an intensive, milestone-driven acceleration programme, designed around 3-stages, each of which is a step closer to market entry: 'Design', 'Develop', 'Market'.

Some high-level benefits include:

  • up to €200K equity-free funding per application experiment;
  • personalized technical and business development support;
  • novel testbed and experimentation facilities;
  • awareness-raising, matchmaking, networking activities;
  • access to investment opportunities;

How to Apply?

The deadline for applications - to be submitted at f6s.com/diatomic-opencall2 - is 31 January 2019. For tips and resources on the application process, check out diatomic.eu. For questions, or to request partner search/ matchmaking support, get in touch: f6s.com/diatomic.

About DIATOMIC

DIATOMIC is a network of Digital Innovation Hubs funded under the European Smart Anything Everywhere Initiative. Eight consortia have already been selected for funding and acceleration in the first DIATOMIC Open Call. Each of the top consortia is expected to create significant value resulting from new microelectronics-enabled products, processes, and business models. The second (and final)call for application experimentscloses on 31stJanuary 2019.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 761809.

Most Popular Now

ChatGPT Shows 'Impressive' Acc…

A new study led by investigators from Mass General Brigham has found that ChatGPT was about 72 percent accurate in overall clinical decision making, from coming up with possible diagnoses...

WiFi SPARK's Healthcare Business Re…

Leading WiFi provider WiFi SPARK is rebranding its healthcare arm as SPARK Technology Services Limited. The new identity marks the completion of the integration of the former Hospedia bedside unit...

Online AI-Based Test for Parkinson'…

An artificial intelligence (AI) tool developed by researchers at the University of Rochester can help people with Parkinson's disease remotely assess the severity of their symptoms within minutes. A study...

ChatGPT is Debunking Myths on Social Med…

ChatGPT could help to increase vaccine uptake by debunking myths around jab safety, say the authors of a study published in the peer-reviewed journal Human Vaccines and Immunotherapeutics. The researchers asked...

AI Performs Comparably to Human Readers …

Using a standardized assessment, researchers in the UK compared the performance of a commercially available artificial intelligence (AI) algorithm with human readers of screening mammograms. Results of their findings were...

Siemens Healthineers Expands Production …

Siemens Healthineers is expanding its site in Rudolstadt, Germany. By mid 2024, a new manufacturing building will be built on the site. The new manufacturing plant will produce electron accelerators...

More Cases of Breast Cancer Detected wit…

One radiologist supported by AI detected more cases of breast cancer in screening mammography than two radiologists working together, reports the ScreenTrustCAD study from Karolinska Institutet in The Lancet Digital...

ChatGPT Performs as Well as Doctors for …

The artificial intelligence chatbot ChatGPT performed as well as a trained doctor in suggesting likely diagnoses for patients being assessed in emergency medicine departments, in a pilot study to be...

Smartphone Technology Expected to Advanc…

Since the 1980s, we have known that neurological soft signs (NSS) can distinguish people with schizophrenia from psychiatrically healthy individuals. NSS are subtle neurological impairments that principally manifest as decreased...

AI may Outperform Most Humans at Creativ…

Large language model (LLM) artificial intelligence (AI) chatbots may be able to outperform the average human at a creative thinking task where the participant devises alternative uses for everyday objects...

MEDICA 2023 + COMPAMED 2023: "Where…

13 - 16 November 2023, Düsseldorf, Germany. The medical technology market is in worldwide motion and the signs ahead of MEDICA 2023 and COMPAMED 2023 in Düsseldorf as the internationally leading...

AI and Machine Learning can Successfully…

Artificial intelligence (AI) and machine learning (ML) can effectively detect and diagnose Polycystic Ovary Syndrome (PCOS), which is the most common hormone disorder among women, typically between ages 15 and...